Dietary targeting of dihydrolipoamide dehydrogenase for stroke tolerance
二氢硫辛酰胺脱氢酶的饮食靶向治疗中风耐受性
基本信息
- 批准号:8506257
- 负责人:
- 金额:$ 25.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-04-01 至 2018-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAffectAntioxidantsAttenuatedBindingBlood - brain barrier anatomyBlood GlucoseBrainBrain InfarctionBrain InjuriesCarboxylic AcidsCause of DeathCell NucleusCessation of lifeChemical AgentsChemicalsChronicClinicalCognitiveComplexCytoplasmDataDevelopmentDietDietary intakeEatingEnzymesExposure toFosteringGeneral PopulationGoalsHippocampus (Brain)HourHumanIndividualInfarctionInjuryInvestigationIschemiaIschemic Brain InjuryIschemic PreconditioningIschemic StrokeKnowledgeLeadLong-Term PotentiationMeasuresMetabolismMiddle Cerebral Artery OcclusionMitochondriaModelingNAD(P)H dehydrogenase (quinone) 1, humanNQO1 geneNuclearPathway interactionsPhenotypePre-Clinical ModelPrevention strategyPreventivePreventive InterventionProteinsRattusRecoveryRecurrenceRegimenReperfusion TherapyResearchResponse ElementsRiskSignal PathwaySignal TransductionStimulusStressStrokeStroke preventionSupplementationSynaptic plasticityTestingTherapeuticUnited StatesWeight GainWithdrawalWorkbasecerebral arterycognitive recoverydietary supplementsdihydrolipoamide dehydrogenasedisabilityexpectationexperiencefeedinghigh riskinhibitor/antagonistmethoxyindoleneurobehavioralneuroprotectionnew therapeutic targetnovelnovel strategiesnovel therapeuticspre-clinicalpreconditioningpreventprophylacticpublic health relevancerespiratorytranscription factor
项目摘要
DESCRIPTION (provided by applicant): New and recurrent stroke is the third leading cause of death and the leading cause of long-term disability in the United States, yet no effective endogenous targets have been defined to prevent or attenuate stroke-induced brain injury. We have discovered that mitochondrial dihydrolipoamide dehydrogenase (DLDH) could be a target for chemical preconditioning against stroke injury. The objective of this application is thus to evaluate the neuroprotective efficacy of DLDH chemical preconditioning and delineate its underlying mechanisms. Our preliminary studies show that when rats were fed a 4-week diet supplemented with 5-methoxyindole-2- carboxylic acid (MICA), a specific and competitive DLDH inhibitor, brain infarction volume decreased by c. 60% after transient middle cerebral artery occlusion (tMCAO, 1 hr ischemia and 24 hr reperfusion). This result indicates that chronic DLDH inhibition by MICA affords robust cerebroprotection against stroke. Further studies of MICA-treated rats in the absence of stroke indicate that DLDH activity was lower than in control rats whilst NAD(P)H: quinone oxidoreductase-1 (NQO1) activity increased significantly in the MICA-treated rats. NQO1 is an inducible enzyme and its expression is activated by binding of the nuclear transcription factor E2-related factor 2 (Nrf2) to the antioxidant response element (ARE). Our preliminary studies also indicate that 4 weeks' MICA dietary administration did not affect food intake, body weight gain, blood glucose concentration, or mitochondrial respiratory complexes. These preliminary results support our central hypothesis that dietary inhibition of DLDH induces persistent cerebroprotection, affording enhanced recovery of cognitive and locomotor function after ischemic stroke, via activation of the Nrf2-ARE signaling cascade. The rationale for the proposed investigation is that identifying nontoxic, blood brain barrier-permeable chemical agents that afford brain protection from stroke, and defining the protective mechanisms, will foster development and clinical implementation of such agents to minimize death and disability in human victims of stroke. We plan to test our central hypothesis and, thereby, accomplish the objective of this application by addressing the following three Specific Aims: (1) To define the extent to which Nrf2 nuclear localization and NQO1 expression increase following MICA administration and tMCAO, (2) To measure the extent to which dietary preconditioning can produce persistent neuroprotection from stroke, and (3) To evaluate the effects of MICA diet and experimental stroke on neurobehavioral function and hippocampal synaptic plasticity measured as CA1 long-term potentiation (LTP). It is expected that the successfully completed study will provide novel strategies using DLDH as a target for stroke therapeutics.
描述(由申请人提供):新发中风和复发性中风是美国第三大死亡原因和长期残疾的主要原因,但尚未确定有效的内源性目标来预防或减轻中风引起的脑损伤。我们发现线粒体二氢硫辛酰胺脱氢酶(DLDH)可以成为针对中风损伤的化学预处理的靶标。因此,本申请的目的是评估 DLDH 化学预处理的神经保护功效并描述其潜在机制。我们的初步研究表明,当大鼠在为期 4 周的饮食中添加 5-甲氧基吲哚-2-羧酸 (MICA)(一种特异性和竞争性 DLDH 抑制剂)时,脑梗塞体积减少了 c.短暂性大脑中动脉闭塞(tMCAO、1 小时缺血和 24 小时再灌注)后 60%。这一结果表明,MICA 的慢性 DLDH 抑制可提供针对中风的强大脑保护作用。对没有中风的 MICA 治疗大鼠的进一步研究表明,DLDH 活性低于对照大鼠,而 NAD(P)H:醌氧化还原酶 1 (NQO1) 活性在 MICA 治疗大鼠中显着增加。 NQO1 是一种诱导酶,其表达通过核转录因子 E2 相关因子 2 (Nrf2) 与抗氧化反应元件 (ARE) 的结合而激活。我们的初步研究还表明,4 周的 MICA 饮食给药不会影响食物摄入、体重增加、血糖浓度或线粒体呼吸复合物。这些初步结果支持我们的中心假设,即饮食抑制 DLDH 可诱导持续的脑保护,通过激活 Nrf2-ARE 信号级联,增强缺血性中风后认知和运动功能的恢复。拟议研究的基本原理是,识别无毒、可渗透血脑屏障的化学制剂,为大脑提供中风保护,并确定保护机制,将促进此类药物的开发和临床实施,以最大限度地减少中风人类患者的死亡和残疾。我们计划测试我们的中心假设,从而通过解决以下三个具体目标来实现本申请的目标:(1)确定 MICA 给药和 tMCAO 后 Nrf2 核定位和 NQO1 表达增加的程度,(2)测量饮食预处理对中风产生持久神经保护作用的程度,以及 (3) 评估 MICA 饮食和实验性中风对神经行为功能和海马突触可塑性(以 CA1 测量)的影响长时程增强(LTP)。预计成功完成的研究将为使用 DLDH 作为中风治疗靶点提供新策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL J. FORSTER其他文献
MICHAEL J. FORSTER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL J. FORSTER', 18)}}的其他基金
Dietary targeting of dihydrolipoamide dehydrogenase for stroke tolerance
二氢硫辛酰胺脱氢酶的饮食靶向治疗中风耐受性
- 批准号:
8620729 - 财政年份:2013
- 资助金额:
$ 25.38万 - 项目类别:
Dietary targeting of dihydrolipoamide dehydrogenase for stroke tolerance
二氢硫辛酰胺脱氢酶的饮食靶向治疗中风耐受性
- 批准号:
9240669 - 财政年份:2013
- 资助金额:
$ 25.38万 - 项目类别:
Dietary targeting of dihydrolipoamide dehydrogenase for stroke tolerance
二氢硫辛酰胺脱氢酶的饮食靶向治疗中风耐受性
- 批准号:
9021008 - 财政年份:2013
- 资助金额:
$ 25.38万 - 项目类别:
相似国自然基金
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
生活方式及遗传背景对成人不同生命阶段寿命及死亡的影响及机制的队列研究
- 批准号:
- 批准年份:2021
- 资助金额:56 万元
- 项目类别:面上项目
成人与儿童结核病发展的综合研究:细菌菌株和周围微生物组的影响
- 批准号:81961138012
- 批准年份:2019
- 资助金额:100 万元
- 项目类别:国际(地区)合作与交流项目
统计学习影响成人汉语二语学习的认知神经机制
- 批准号:31900778
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
- 批准号:
10676358 - 财政年份:2024
- 资助金额:
$ 25.38万 - 项目类别:
A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
- 批准号:
10752276 - 财政年份:2024
- 资助金额:
$ 25.38万 - 项目类别:
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:
10822202 - 财政年份:2024
- 资助金额:
$ 25.38万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 25.38万 - 项目类别:
Identifying and testing a tailored strategy to achieve equity in blood pressure control in PACT
确定并测试量身定制的策略,以在 PACT 中实现血压控制的公平性
- 批准号:
10538513 - 财政年份:2023
- 资助金额:
$ 25.38万 - 项目类别: